Molecular methods for rapid detection of group B streptococci

Expert Review of Molecular Diagnostics

Volumn 1, Issue 2, 2001, Pages 175-181

  Ke, Danbing ^a   Bergeron, Michel G ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Group B streptococci; Intrapartum antibiotic prophylaxis; LightCycler; Pregnant women; Real time PCR; Smart Cycler; Streptococcus agalactiae

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CHEMOPROPHYLAXIS; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG INDICATION; DRUG USE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HYBRIDIZATION; INFECTION PREVENTION; INFECTION RISK; LATEX AGGLUTINATION TEST; MENINGITIS; NEWBORN; NEWBORN SEPSIS; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TREATMENT INDICATION;

EID: 0035559297     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.1.2.175     Document Type: Review

References (52)

1. Streptococcus
2. Streptococcus agalactiae mastitis: A review
3. Neonatal sepsis and other infections due to group B β-hemolytic streptococci
4. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
5. Group B streptococcal disease in the United States, 1990: Rport from a multistate active surveillance system
6. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis
7. Group B streptococcus
8. Strategies for chemoprophylaxis of GBS early-onset infections
9. Ampicillin prevents intrapartum transmission of group B streptococcus
10. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis
11. Potential consequences of widespread antepartal use of ampicillin
12. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study
13. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: The superiority of culture-based protocols
14. Centers for Disease Control and Prevention: Prevention of perinatal group B streptococcal disease: A public health perspective
15. Opportunities for prevention of perinatal group B streptococcal disease: A multistate surveillance analysis
16. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery
17. Nonhemolytic group B streptococcal infections
18. Presumptive identification of group A, B and D streptococci
19. New granada medium for detection and identification of group B streptococci
20. Evaluation of the granada agar plate for detection of vaginal and rectal group B streptococci in pregnant women
21. Use of granada medium to detect group B streptococcal colonization in pregnant women
22. Assessment of rapid identification tests for genital carriage of group B streptococci
23. Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers
24. Direct detection of group B streptococci from vaginal specimens compared with quantitative culture
25. Rapid identification of pregnant women heavily colonized with group B streptococci
26. Neonatal group B streptococcal disease-screening and prevention
27. Enhanced antenatal detection of group B streptococcus colonization
28. Comparison of NNA agar culture and selective broth culture for detection of group B streptococcal colonization in women
29. Use of a DNA-probe for the rapid detection of group B streptococci in obstetric patients
30. Use of Gen-Probe AccuProbe Group B streptococcus test to detect group B streptococci in broth cultures of vaginal-anorectal specimens from pregnant women: Comparison with traditional culture method
31. Performance of a new DNA probe for the detection of group B streptococcal colonization of the genital tract
32. Detection of the C protein gene among group B streptoccci using PCR
33. Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples
34. An approach to the identification of the pathogens of bacterial meningitis by the polymerase chain reaction
35. V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis
36. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci
37. Rapid detection of group B streptococci in pregnant women at delivery
38. Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor
39. Real time quantitative PCR
40. The LightCycler™: A microvolume multisample fluorimeter with rapid temperature control
41. Identification of pathogenic Leptospira genospecies by continuous monitoring of fluorogenic hybridization probes during rapid-cycle PCR
42. Continuous fluorescence monitoring of rapid cycle DNA amphfication
43. A miniature analytical instrument for nucleic acids based on micromachined silicon reaction chambers
44. Rapid, automated nucleic acid probe assays using silicon microstructures for nucleic acid concentration
45. Rapid PCR detection of group B streptococci in pregnant women from vaginal/anal specimen using the Smart Cycler
46. Molecular beacons: Probes that fluoresce upon hybridization
47. Preparation and hybridization analysis of DNA/RNA from E. coli on microfabricated bioelectronic chips